Hsiao Lieu is VP & Clinical Research at Nile Therapeutics, Inc. (NLTX). They have made 1 open-market trade across 1 company since 2008, most recently 2008-04-15.
CIK 0001468482
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $460 since 2008, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NLTX | 100 | $1K |
Shares reported on the most recent Form 4, priced at the 2009-07-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NLTX | BUY | 2008-04-15 | 2009-07-20 | $4.60 | $460 | -0.3% | +2.4% | +2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.